HMGB1 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, 5-FU sensitivity (IC50) increased by 1.05-fold for HMGB1 and 1.3-fold for CML-HMGB1 in comparison with untreated TMK1 cells (Figure 3F).